BSECompany Update21 Aug 2026 · 21 Aug 2026, 02:32 pm
Intimation regarding appointment of Mr. Sunil Sharma and resignation of Ms. Seema Salvi as HOD injectable
Mercury Laboratories Ltd · 538964
✦ AI SummaryMgmt Change
Mercury Laboratories Ltd has announced the appointment of Mr. Sunil Sharma as Head of the Department (Injectable Production) and the resignation of Ms. Seema Salvi from the same position, effective August 21, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Mercury Laboratories Ltd - 538964 - Announcement under Regulation 30 (LODR)-Change in Management
Attachments (1)
📄pdf
Download →
fb7e0d06-4a9c-430d-9c25-17c4a70d0192.pdf
View document text
Date: 21/08/2026
Corporate Relations Department
BSE Limited
Phiroze Jeejeebhoy Towers,
25th Floor, Dalal Street,
Mumbai – 400 001
Scrip Code: 538964
Subject: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 for appointment and resignation of Senior Management
Personnel (SMP).
Dear Sir/Madam,
Pursuant to Regulation 30 read with Para A(7) of Part A of Schedule III of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we would like to inform you
that
1. Mr. Sunil Sharma has been appointed as Head of the Department (Dept.-Injectable Production) of
the Company with effect from August 21, 2026.
2. Ms. Seema Salvi, Head of the Department (Dept.-Injectable Production) designated as Senior
Management Personnel (SMP) of the Company has tendered her resignation for better
opportunities and career advancement.
It is further informed that there is no other material reason for the resignation other than the reason
mentioned in Annexure-A. The said resignation letter is enclosed herewith as Annexure-B.
The details of changes as required under Regulation 30 of SEBI (LODR) Regulations, 2015 read with
Section V-A of Chapter V of Master Circular issued vide circular no.
SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated July 11, 2023 and SEBI/HO/CFD/CFD-PoD-
1/P/CIR/2023/123 dated July 13, 2023 is enclosed herewith as Annexure-A.
You are requested to take the above information on record.
Thanking You!
Yours faithfully,
For Mercury Laboratories Limited
Rajendra Shah
Managing Director
DIN 00257253
Encl: As above
Annexure-A
Sr. Details of Information Information of such events
No required to be provided
Mr. Sunil Sharma Ms. Seema Salvi
1. Reason for change viz. Mr. Sunil Sharma appointed Ms. Seema Salvi, HOD-
appointment, resignation, as Head of the Department Injectable Production
reappointment, (Dept.-Injectable Production) designated as Senior
removal, death Management Personnel (SMP)
or otherwise of the Company has tendered
her resignation for better
opportunities and career
advancement. There is no
other material reason for the
resignation other than the
reason mentioned in
resignation letter.
2. Date of Date of appointment: August Date of Cessation : August 21,
Appointment/Cessation & 21, 2026 2026 (Closure of business
term of appointment Term of appointment: Full hours)
time employment.
3. Brief profile (in case of Mr. Sunil Sharma, age about Not applicable
appointment) 45 years, holds Bachelor
degree in Pharmacy
(B.Pharm). He has rich
experience of more than 19
years in the field of Injection
Production. Earlier he was
associated with Flagship
Biotech International Pvt Ltd,
Bharat Parentals Limited,
Intas Pharmaceuticals
Limited and Sun Pharma.
4. Disclosure of relationships Not applicable Not applicable
between directors (in case
of appointment of a
director).
Date: 21/08/2026
Managing Director
Mercury Laboratories Limited
Sub: Notice of Resignation from MercuryL aboratoriesL imited
Respected Sir,
With reference to above captioned subject, I hereby tender my resignation from the position of
Head of the Department (Injectable Production) of the Company for better opportunities and
career advancement
Therefore, I kindly request the management to accept my resignation and relieve me from my
duties with the effect from the closure of business hours on 21/08/2026
It was pleasure and privilege to be part of Mercury Laboratories Limited. I deeply grateful for
the opportunities guidance and support received throughout my tenure. I would like to thank
all board members and my colleagues for their guidance, support and cooperation during my
tenure with the Company.
Kindly acknowledge the receipt of this Resignation letter
With~s,
Ms. Seema Salvi